|
241 |
Cipla to ramp up front-end in US, Europe |
Download (71.54 KB)  |
04/09/2014 |
|
242 |
Cipla Europe launches may trigger rerating |
Download (54.48 KB) |
04/09/2014 |
|
243 |
Glenmark may be the dark horse in domestic Pharma |
Download (55.77 KB) |
03/09/2014 |
|
244 |
Nod for combination inhaler breathes fresh life into cipla |
Download (53.54 KB) |
03/09/2014 |
|
245 |
Cipla targets US with Glaxo advair |
Download (36.33 KB) |
02/09/2014 |
|
246 |
Venus Remedies up 15.5% on tie-up with Israel Teva |
Download (21.83 KB) |
28/08/2014 |
|
247 |
Shasun Pharma narrows losses |
Download (24.74 KB) |
28/08/2014 |
|
248 |
Piramal enterprises to stop early-stage research |
Download (91.79 KB) |
28/08/2014 |
|
249 |
Sun Pharma promoter group fined |
Download (23.48 KB) |
28/08/2014 |
|
250 |
Cipla has a buy rating |
Download (32.16 KB) |
28/08/2014 |
|
251 |
Strides gets USFDA nod for generic anti-anxiety tablets |
Download (29.16 KB) |
27/08/2014 |
|
252 |
Sanofi India: Relief a few quarters away |
Download (50.22 KB) |
27/08/2014 |
|
253 |
Pfizer thane plant faces uncertainty as lockout notice lapses |
Download (53.39 KB) |
23/08/2014 |
|
254 |
Packaging norms: DRL sees US liability |
Download (24.85 KB) |
23/08/2014 |
|
255 |
US slaps 240-cr fine on Ranbaxy over inflated drug prices |
Download (43.94 KB) |
22/08/2014 |
|
256 |
Claris gets UK regulator nod for Ahmedabad unit |
Download (20.55 KB) |
22/08/2014 |
|
257 |
DRL breached packaging rules: US regulator |
Download (25.64 KB) |
22/08/2014 |
|
258 |
Zydus cadila gets USFDA nod for anti-viral drug |
Download (23.5 KB) |
21/08/2014 |
|
259 |
Venus gets authorisation from Swiss drug authority |
Download (34.32 KB) |
21/08/2014 |
|
260 |
Novartis licences drugs deal |
Download (23.81 KB) |
21/08/2014 |
औषध विभाग
Department of
